This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: ADI HES ONNN PANW S

Linear Technology (LLTC) was upgraded at Jefferies to buy. $44 price target. Company is leveraged to higher automotive and industrial growth, Jefferies said.

Optical Cable (OCC) was downgraded to hold at TheStreet Ratings.

ON Semiconductor (ONNN) was downgraded at Jefferies to hold. $8.50 price target. Company may face multiple compression, as the chip sector is entering the late innings of the cycle, Jefferies said.
[Read: <a target="blank" data-add-tracking="true" href="http://www.mainstreet.com/node/28601"><em>5 Cars That Are Perfect for New College Grads</em></a>]

Palo Alto Networks (PANW - Get Report) was upgraded at UBS to buy from neutral. Unjustified low valuation despite industry leading growth, said UBS. Price target is $55.

Sprint Nextel (S) was downgraded at Citigroup to neutral from buy. Margin expansion from Network Vision is priced in, said Citigroup. Price target is now $7.50.

Sprint Nextel was upgraded at Deutsche Bank to buy from hold. New analyst has an $8 price target. Company will be the king of new spectrum and can drive above-average growth over the next few years, Deutsche Bank said.

Tenet Healthcare (THC) was initiated with a hold rating at Keybanc. Valuation call, as the stock is up 115% over the past year, Keybanc said.

STOCK COMMENTS/EPS CHANGES

AmerisourceBergen (ABC) numbers were boosted at Credit Suisse. Shares are now seen reaching $64. WAG deal should add to earnings, Credit Suisse said. Outperform rating.

Allergan (AGN) price target was reduced at Lazard Capital Markets. Shares are now seen reaching $100. Restasis could face increased competition from generics, Lazard Capital Markets said. Buy rating.

Axiall (AXLL) numbers were cut at UBS. Earnings estimates were reduced on weak demand and operation issues, said UBS said. Price target is reduced to $44.

CBS (CBS) price target was raised at Citigroup to $54. Reflects buyback enthusiasm, said Citigroup.

Family Dollar (FDO) numbers were raised at Goldman Sachs. Shares are now seen reaching $69. Estimates were also increased, as the company is realizing better operating leverage, Goldman Sachs said. Neutral rating.

Mead Johnson Nutrition (MJN) numbers were cut at Citigroup. Estimates were reduced given ongoing issues in Hong Kong, dairy inflation and China price pressures, said Citigroup. Price target goes to $77.

National Retail (NNN) estimates were raised at UBS. Reflect the recent financing and increased acquisition estimates, said UBS. Price target is $33.50.

Occidental Petroleum (OXY) price target was boosted at Citigroup to $93. A potential breakup should lead to limited upside in the stock, Citi said.

Synchronoss (SNCR) was added to the Best Ideas List at Wedbush. Pullback has created an attractive buying opportunity, Wedbush said. Outperform rating and $35 price target.

>To submit a news tip, email: tips@thestreet.com.

Follow TheStreet on Twitter and become a fan on Facebook.
This article was written by a staff member of TheStreet.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
ONNN $0.00 0.00%
ADI $64.38 -0.29%
HES $65.71 0.44%
PANW $173.90 -1.27%
S $4.48 -0.88%

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs